Indivior PLC announced the appointment of Vanessa Procter as Executive Vice President of Corporate Affairs, effective July 7, 2025. Vanessa is a seasoned corporate affairs leader with extensive experience in the biopharmaceutical industry, and will be responsible for Corporate Communications, Government Affairs, Policy and Advocacy at Indivior. Ms. Procter brings 25 years of experience in the biopharmaceutical industry, having led corporate and government affairs for multiple organizations.
Most recently, Ms. Procter was Senior Vice President of Corporate Affairs at Sage Therapeutics, where she led a team that conditioned the environment for the successful product launch of ZURZUVAE?, the first pill for post-partum depression. In that role, she led corporate communications, investor relations, government affairs and patient advocacy. Prior to her time at Sage, she was Head of U.S. Government Affairs and Public Policy at Alexion Pharmaceuticals, helping expand patient access to existing and new medical therapies.
Earlier, Ms. Procter worked at MedImmune as Director of Federal Government Affairs. Before that, she was a health policy advisor in the U.S. House of Representatives.Ms. Procter earned her B.A. in History from Gettysburg College.
